Loading stock…
ALNY
Healthcare / BiotechnologyAlnylam Pharmaceuticals Inc
227.02-5.66 (-2.43%)After-hours — · session close 2026-10-12
Revenue EPS
| Date | EPS Est | EPS Actual | Surprise % | 1-day result |
|---|---|---|---|---|
| 2026-07-302026Q2 · BMO | 1.44 | 1.21 | -16.0% | -8.7% |
| 2026-04-302026Q1 · BMO | 1.47 | 1.99 | +35.4% | +0.7% |
| 2026-02-122025Q4 · BMO | 1.50 | 1.25 | -16.7% | -1.9% |
| 2025-10-302025Q3 · BMO | 1.75 | 2.90 | +65.7% | -0.1% |
| 2025-07-312025Q2 · BMO | 0.15 | 0.32 | +113.3% | +12.1% |
| 2025-05-012025Q1 · BMO | -0.37 | -0.01 | +97.3% | -0.8% |
| 2025-02-132024Q4 · BMO | -0.14 | 0.06 | +142.9% | +2.4% |
| 2024-10-312024Q3 · BMO | -0.39 | -0.50 | -28.2% | -3.2% |
| 2024-08-012024Q2 · BMO | -0.69 | 0.56 | +181.2% | +7.4% |
| 2024-05-022024Q1 · BMO | -0.63 | -0.16 | +74.6% | -0.3% |
| 2024-02-152023Q4 · BMO | -0.77 | -0.77 | 0.0% | -1.7% |
| 2023-11-022023Q3 · BMO | -0.96 | 1.74 | +281.3% | -0.5% |